Related Experiment Video
Updated: Jul 4, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Clinicopathological and survival analysis of primary spindle cell carcinoma of the breast in Chinese patients
Xiaoyan Qian1,2, Min Xiao1,3, Yang Liu1,4
1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021, China.
Spindle cell carcinoma (SpCC) of the breast, though often early-stage, has a poor prognosis. T stage is a key factor for overall survival, indicating a need for improved treatments.
Area of Science:
- Oncology
- Pathology
Background:
- Spindle cell carcinoma (SpCC) of the breast is rare, limiting understanding of its characteristics.
- Limited data exists on SpCC in Chinese populations.
Purpose of the Study:
- To analyze clinicopathological features of breast SpCC in Chinese patients.
- To evaluate survival outcomes and prognostic factors for breast SpCC.
Main Methods:
- Retrospective analysis of 160 breast SpCC cases (23 from author's center, 137 from literature).
- Data collected from 2004-2021, including clinical, pathological, and survival information.
- Literature search conducted on Chinese databases and PubMed.
Main Results:
- Median age was 52; 84.8% diagnosed at early stages (I/II).
- Low axillary lymph node involvement (15.0%); majority HR-HER2- (85.4%).
- High recurrence rate (46.0%) with lung metastasis common; 3-year DFS 55.9%, 3-year OS 67.0%. T stage independently predicted OS.
Conclusions:
- Breast SpCC often presents early but has a poor prognosis.
- T stage is a significant prognostic factor for overall survival.
- Further research is needed to develop better treatments to improve outcomes and prevent recurrence.
Related Concept Videos
Cancer Survival Analysis
Comparing the Survival Analysis of Two or More Groups

